By tracking previous views Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) also in plain sight to attract passive investors, shares in most recent trading session showed upbeat performance 19.61% after traded at $2.44.
While to figure out more clear vision, firm’s returns on investment calculated as -107.30%; it gives answer about efficiency of different investments in different securities. The returns on assets of firm also presenting perceptible condition of profitability, it has ROA of -126.20%, the very positive ratio starts from >+15% and very negative hits to <-15%.
The firm has noticeable volatility credentials, price volatility of stock was 9.49% for a week and 11.03% for a month. The performance of firm for the quarter recorded as -8.27% and for year stands at -11.27%, while the YTD performance was -18.94%. The co attains 0.28 for Average True Range for 14 days. The stock price of EBIO is moving down from its 20 days moving average with -8.49% and isolated negatively from 50 days moving average with -35.79%.
ImmunoGen, Inc. (NASDAQ:IMGN) persists its position slightly strong in context of buying side, while shares price are rising -0.43% during latest trading session.
The returns on assets of firm also on noticeable level, it has ROA of -55.30%, which signifies how profitable a firm is relative to its total assets. To make strengthen this views, the active industry firm has Quick Ratio of 4.10, which indicates firm has sufficient short-term assets to cover its immediate liabilities. Taking notice on volatility measures, price volatility of stock was 5.28% for a week and 4.60% for a month.